Synthetic-polymer-assisted antisense oligonucleotide delivery: targeted approaches for precision disease treatment

• Ana Cubillo Alvarez,
• Dylan Maguire and
• Ruairí P. Brannigan

Beilstein J. Nanotechnol. 2025, 16, 435–463, doi:10.3762/bjnano.16.34

• complexed PLR (Mw = 15–70 kDa) with hyaluronic acid (HA) to form biodegradable nanoparticles capable of delivering siRNA to cells overexpressing the HA receptor CD44. The study demonstrated that these HA–PLR complexes, in particular the formulation HP101, were able to form stable complexes with siRNA and

Development of a mucoadhesive drug delivery system and its interaction with gastric cells

• Ahmet Baki Sahin,
• Serdar Karakurt and
• Deniz Sezlev Bilecen

Beilstein J. Nanotechnol. 2025, 16, 371–384, doi:10.3762/bjnano.16.28

• both situations, the effectiveness of the drug formulation depends on several factors such as gastric residence time, gastric emptying, release rate of the drug from the dosage form, and the therapeutic agent reaching the site of action or absorption. Conventional drug delivery systems may not be

• system to be used in stomach delivery applications. In one study, alginate and various mucoadhesive polymers, including Eudragit RS100, were blended to deliver an anti-ulcerative drug to the stomach for prolonged gastric retention. Approximately 67% of an Eudragit microsphere formulation was found to

• protein-digesting enzyme pepsin [44]. Despite the challenges, remarkable developments are unfolding. Recently a peptide-based therapeutic delivery system that is absorbed in the stomach was approved by the FDA as oral formulation to be used in type-II diabetic patients [45]. This inspired us to develop

Radiosensitizing properties of dual-functionalized carbon nanostructures loaded with temozolomide

• Radmila Milenkovska,
• Nikola Geskovski,
• Dushko Shalabalija,
• Ljubica Mihailova,
• Petre Makreski,
• Dushko Lukarski,
• Igor Stojkovski,
• Maja Simonoska Crcarevska and
• Kristina Mladenovska

Beilstein J. Nanotechnol. 2025, 16, 229–251, doi:10.3762/bjnano.16.18

• concentration-dependent toxicity was observed for blank dual-functionalized CNs, being higher for MWCNTs-G-PEG6000-FA compared to MWCNTs-PEG6000-FA at the same formulation concentrations. With incorporation of TMZ into the functionalized CNs, the cell viability additionally decreased, maintaining the trend for

• formulation, biopharmaceutics/release kinetics, and pharmacokinetics of TMZ. Also, surface functionalization attempts with multiple targeting ligands were made to deliver TMZ to the site of interest, exploiting the site-specific expression or overexpression of specific molecules on BBTB and GBM cells to

• -modified hybrid structure could also explain the faster TMZ release from this formulation in comparison with the functionalized ones (Figure 2b). After irradiation, the TMZ release from the dual-functionalized CNs was slightly faster, which can be attributed to the changes in the size of the CNs, faster

Synthesis and the impact of hydroxyapatite nanoparticles on the viability and activity of rhizobacteria

• Bedah Rupaedah,
• Indrika Novella,
• Atiek Rostika Noviyanti,
• Diana Rakhmawaty Eddy,
• Anna Safarrida,
• Abdul Hapid,
• Zhafira Amila Haqqa,
• Suryana Suryana,
• Irwan Kurnia and
• Fathiyah Inayatirrahmi

Beilstein J. Nanotechnol. 2025, 16, 216–228, doi:10.3762/bjnano.16.17

• ) and precise digital measurement of electrical conductivity (Mettler Toledo, MC 226 conductivity meter). Preparation of inoculum and formulation of rhizobacteria-nHA nHA was carefully placed into 2 mL EP tubes and underwent sterilization through autoclaving. The rhizobacteria were introduced into

Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy

• Naths Grazia Sukubo,
• Paolo Bigini and
• Annalisa Morelli

Beilstein J. Nanotechnol. 2025, 16, 97–118, doi:10.3762/bjnano.16.10

• macrophage-based systems for nanomedical applications and immunotherapeutic strategies in asthma treatment [112]. Researchers have developed an inhalable formulation of Roflumilast using lipid–polymer hybrid nanoparticles (LPHNPs) to improve its delivery to the lungs and specifically target AMs in COPD

Instance maps as an organising concept for complex experimental workflows as demonstrated for (nano)material safety research

• Benjamin Punz,
• Maja Brajnik,
• Joh Dokler,
• Jaleesia D. Amos,
• Litty Johnson,
• Katie Reilly,
• Anastasios G. Papadiamantis,
• Amaia Green Etxabe,
• Lee Walker,
• Diego S. T. Martinez,
• Steffi Friedrichs,
• Klaus M. Weltring,
• Nazende Günday-Türeli,
• Claus Svendsen,
• Christine Ogilvie Hendren,
• Mark R. Wiesner,
• Martin Himly,
• Iseult Lynch and
• Thomas E. Exner

Beilstein J. Nanotechnol. 2025, 16, 57–77, doi:10.3762/bjnano.16.7

Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications

• Hugo Felix Perini,
• Beatriz Sodré Matos,
• Carlo José Freire de Oliveira and
• Marcos Vinicius da Silva

Beilstein J. Nanotechnol. 2024, 15, 1619–1626, doi:10.3762/bjnano.15.127

• nanoparticles (AuNPs) with polyoxometalate and the peptides POMD and LPFFD (AuNPs@POMD-pep) have shown inhibition of Aβ1 aggregation and Aβ-induced cytotoxicity. However, the inherent toxicity of this formulation, challenges in particle digestion, and the potential for triggering immune reactions remain

Integrating high-performance computing, machine learning, data management workflows, and infrastructures for multiscale simulations and nanomaterials technologies

• Fabio Le Piane,
• Mario Vozza,
• Matteo Baldoni and
• Francesco Mercuri

Beilstein J. Nanotechnol. 2024, 15, 1498–1521, doi:10.3762/bjnano.15.119

• across the framework, guaranteeing consistency from the formulation of queries to the definition of tasks. Ontologies, in particular, constitute an efficient and common way to formally represent knowledge. Accordingly, recent collaborative work has focused on the development of materials ontologies

• largely missing. The development of MAMBO followed an hybrid approach mixing top-down and bottom-up processes. To accurately capture the distinct characteristics of concepts integral to the formulation of the MAMBO ontology (both the more general concepts and the more specific ones), we initially

Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects

• Iqra Rahat,
• Pooja Yadav,
• Aditi Singhal,
• Mohammad Fareed,
• Jaganathan Raja Purushothaman,
• Mohammed Aslam,
• Raju Balaji,
• Sonali Patil-Shinde and
• Md. Rizwanullah

Beilstein J. Nanotechnol. 2024, 15, 1473–1497, doi:10.3762/bjnano.15.118

• scavenging capability of the developed formulation was comparable to that of standard antioxidants such as vitamins C and E. The antioxidant capabilities of RVT and the developed PLHNPs were further assessed by determining improved superoxide dismutase (SOD) activities in lipopolysaccharide-induced J774A.1

• improved antitumor efficacy against cervical cancer [139]. The formulation showed better stability and sustained release properties. Antitumor activity in U14 tumor-bearing female CD-1 mice revealed that the UA-PLHNPs exhibited much higher tumor growth inhibition. Further, UA-PLHNPs represented better

Effect of radiation-induced vacancy saturation on the first-order phase transformation in nanoparticles: insights from a model

• Aram Shirinyan and
• Yuriy Bilogorodskyy

Beilstein J. Nanotechnol. 2024, 15, 1453–1472, doi:10.3762/bjnano.15.117

• HDCMs’ behavior under irradiation. Recently, we attempted to adapt Shen’s model for polymorphic transformations in nanoscale Fe systems (conference report, providing an initial approximation to the formulation of the problem) [19]. However, certain assumptions raise doubts about the results, namely, (i

Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals

• Selin Akpinar Adscheid,
• Akif E. Türeli,
• Nazende Günday-Türeli and
• Marc Schneider

Beilstein J. Nanotechnol. 2024, 15, 1400–1414, doi:10.3762/bjnano.15.113

• alternative route of administration [60]. For instance, Dhaliwal et al. presented a cationic liposomal formulation loaded with luciferase mRNA to evaluate the intranasal delivery to the brain in a murine model. Positively charged liposomes both enhance the interactions with anionic mRNA, leading to complexes

• between these materials, and the intracellular uptake for gene delivery. The authors encapsulated luciferase mRNA in the cationic liposomal formulation to quantify the mRNA expression distribution in the brain. The results of the in vivo studies with mice showed a dose-dependent increase in luciferase

• activity in the whole brain after the administration. Moreover, compared to the mRNA administration without liposomal formulation, the encapsulated mRNA showed higher mRNA expression than the control group, indicating successful delivery of mRNA through intranasal delivery [96]. While the results are

A biomimetic approach towards a universal slippery liquid infused surface coating

• Ryan A. Faase,
• Madeleine H. Hummel,
• AnneMarie V. Hasbrook,
• Andrew P. Carpenter and
• Joe E. Baio

Beilstein J. Nanotechnol. 2024, 15, 1376–1389, doi:10.3762/bjnano.15.111

• adhesion to the surface. This hemocompatibility work suggests that PDA SLIPS coatings slow or prevent clotting, but the observation of both FXII activation and the presence of adherent and activated platelets at the PDA SLIPS samples imply that this formulation of a SLIPS coating is not completely

• was no difference in platelet adhesion between PDA–FDT–PFD, COC, and glass for donor A1. However, glass exhibited significantly higher platelet adhesion than PDA–FDT–PFD and COC for donor A3 (Figure 7). Combined, these biocompatibility assays demonstrate that this formulation of a SLIPS coating is not

Realizing active targeting in cancer nanomedicine with ultrasmall nanoparticles

• André F. Lima,
• Giselle Z. Justo and
• Alioscka A. Sousa

Beilstein J. Nanotechnol. 2024, 15, 1208–1226, doi:10.3762/bjnano.15.98

• performance of the targeted C’ dot formulation with an antibody drug conjugate using both 3D tumor spheroid models and xenograft animal tumor models. The results indicated that the C’ dots exhibited significantly deeper penetration within 3D cell-line-derived spheroids (Figure 3C). Additionally, the particles

Synthesis, characterization and anticancer effect of doxorubicin-loaded dual stimuli-responsive smart nanopolymers

• Ömür Acet,
• Pavel Kirsanov,
• Burcu Önal Acet,
• Inessa Halets-Bui,
• Dzmitry Shcharbin,
• Şeyda Ceylan Cömert and
• Mehmet Odabaşı

Beilstein J. Nanotechnol. 2024, 15, 1189–1196, doi:10.3762/bjnano.15.96

• that observed for the commercial liposomal formulation of doxorubicin Doxil. The obtained results demonstrated that smart nanopolymers can be efficiently used to create new types of doxorubicin-based drugs. Keywords: cancer cell line HeLa; cytotoxicity; doxorubicin; drug delivery; smart nanopolymers

• against the cancer cell line Hela at different DOX concentrations and incubation times showed a prolonged DOX release and a good anticancer effect. The effect was similar to that observed in a commercial liposomal formulation of doxorubicin (Doxil) as well as to that of other polymeric formulations of DOX

AI-assisted models to predict chemotherapy drugs modified with C₆₀ fullerene derivatives

• Jonathan-Siu-Loong Robles-Hernández,
• Dora Iliana Medina,
• Katerin Aguirre-Hurtado,
• Marlene Bosquez,
• Roberto Salcedo and
• Alan Miralrio

Beilstein J. Nanotechnol. 2024, 15, 1170–1188, doi:10.3762/bjnano.15.95

• represented by the following functional form: AI3DRUG = f(WS, LogS, α, NOR, ω, ELUMO, EHOMO, PSA, pKa, LogP). The model with the lowest MAPE among those obtained by MLR, computed as 11.98%, is model 3, represented as follows: Thus, the AI was useful in selecting the most relevant variables for the formulation

Quantum-to-classical modeling of monolayer Ge₂Se₂ and its application in photovoltaic devices

• Anup Shrivastava,
• Shivani Saini,
• Dolly Kumari,
• Sanjai Singh and
• Jost Adam

Beilstein J. Nanotechnol. 2024, 15, 1153–1169, doi:10.3762/bjnano.15.94

• variation formulation Edp = ∂Eedge/∂δ, where Eedge is the valence and conduction band edge, and Edp is computed by imposing a compressive and tensile strain δ to the unit cell. After substituting the values of Edp, elastic constant C, and average effective mass md, we calculate the mobility of the charge

Recent updates in applications of nanomedicine for the treatment of hepatic fibrosis

• Damai Ria Setyawati,
• Fransiska Christydira Sekaringtyas,
• Riyona Desvy Pratiwi,
• A’liyatur Rosyidah,
• Rohimmahtunnissa Azhar,
• Nunik Gustini,
• Gita Syahputra,
• Idah Rosidah,
• Etik Mardliyati,
• Tarwadi and
• Sjaikhurrizal El Muttaqien

Beilstein J. Nanotechnol. 2024, 15, 1105–1116, doi:10.3762/bjnano.15.89

• the FDA up to 2019 [46]. They consist of PLGA microparticles, solid implants, and in situ gels; none of them is a PLGA NP formulation. This fact indicates that there are some challenges, including poor drug entrapment efficiency and drug release kinetics from PLGA nanoformulations [47]. Regarding

Unveiling the potential of alginate-based nanomaterials in sensing technology and smart delivery applications

• Shakhzodjon Uzokboev,
• Khojimukhammad Akhmadbekov,
• Ra’no Nuritdinova,
• Salah M. Tawfik and
• Yong-Ill Lee

Beilstein J. Nanotechnol. 2024, 15, 1077–1104, doi:10.3762/bjnano.15.88

• , researchers have improved the formulation procedures for alginate-based nanoparticles to improve drug-loading capacity, stability, and controlled release characteristics. To improve the formulation of alginate nanoparticles, several methods have been developed, including emulsion-based approaches, solvent

Therapeutic effect of F127-folate@PLGA/CHL/IR780 nanoparticles on folate receptor-expressing cancer cells

• Thi Ngoc Han Pham,
• Phuong-Thao Dang-Luong,
• Hong-Phuc Nguyen,
• Loc Le-Tuan,
• Xuan Thang Cao,
• Thanh-Danh Nguyen,
• Vy Tran Anh and
• Hieu Vu_Quang

Beilstein J. Nanotechnol. 2024, 15, 954–964, doi:10.3762/bjnano.15.78

• water for three days (the water was changed twice a day). The solution was then freeze-dried for three days and stored at −80 °C until usage. The final product was confirmed by NMR analysis (Supporting Information File 1, Figure S1). Formulation of F127-folate@PLGA/CHL/IR780 nanoparticles In

• content in the formulation was determined according to Drug release from nanoparticles The F127-folate@PLGA/CHL/IR780 were kept in diluted 0.1× PBS (NaCl 13.7 mM, KCl 0.27 mM, NaH2PO4 1 mM, and KHPO4 0.18 mM) and incubated at 37 °C for various time points, (24, 48, 72, and 168 h) at 37 °C at pH 7.4 and

• in cancer treatment. Conclusion In this work, we designed F127-folate@PLGA nanoparticles capable of carrying CHL and IR780. The formulation approach has produced nanoparticles of extremely homogeneous size. The F127-folate polymer on the surface of nanoparticles made it easier for nanoparticles to

Electrospun nanofibers: building blocks for the repair of bone tissue

• Tuğrul Mert Serim,
• Gülin Amasya,
• Tuğba Eren-Böncü,
• Ceyda Tuba Şengel-Türk and
• Ayşe Nurten Özdemir

Beilstein J. Nanotechnol. 2024, 15, 941–953, doi:10.3762/bjnano.15.77

• regeneration and give an insight about bone regeneration, production techniques of the electrospun nanofibers, and varying formulation parameters in order to reach different drug delivery goals. This review also provides an extensive market research of electrospun nanofibers and an overview on scientific

• additives in the nanofiber matrix cause an increase in the release of active material through the water-filled pores in the system [4][94][95]. Pores are created in the eroded polymeric structure and accelerate the release rates [32]. Formulation components of polymeric nanofibers The basic components of

• . Hence, polymers are the most important formulation components in the preparation of nanofibers with a structure similar to natural bone tissue for bone regeneration [96]. The content and alignment of the polymeric structure of the nanofibers is important for the alignment of the collagenous fibers in

When nanomedicines meet tropical diseases

• Eder Lilia Romero,
• Katrien Van Bocxlaer and
• Fabio Rocha Formiga

Beilstein J. Nanotechnol. 2024, 15, 830–832, doi:10.3762/bjnano.15.69

• article collection. Among the articles, an interesting strategy to improve the bioavailability of benzonidazole towards Chagas disease has been presented by Muraca and colleagues, who reported a stable and safe nanostructured lipid formulation with potential effects against Trypanosoma cruzi [2]. In turn

Cholesterol nanoarchaeosomes for alendronate targeted delivery as an anti-endothelial dysfunction agent

• Horacio Emanuel Jerez,
• Yamila Roxana Simioni,
• Kajal Ghosal,
• Maria Jose Morilla and
• Eder Lilia Romero

Beilstein J. Nanotechnol. 2024, 15, 517–534, doi:10.3762/bjnano.15.46

• of this research suggest that the endocytosis of one specific formulation, nanoARC-Chol(ALN), by irritated HUVECs in the mild inflammation model, was beneficial. The same as dexamethasone, nanoARC-Chol(ALN) was partly capable of reducing the morphological changes caused by LPS, potentially caused by

• tyrosine phosphorylation, actin depolymerization, and gap formation on the actin cytoskeleton [64]. However, the most important finding reported here is that nanoARC-Chol(ALN) was the only formulation capable of reducing the secretion of IL-6 and IL-8 by HUVECs, not only in the mild but also in the

• due to the lower ALN internalization, resulting from the lower ALN/lipid ratio and lower endocytosis of the formulation. In either case, the mechanism of reduction of IL-6/IL-8 of ALN-loaded nanoarchaeosomes would differ from that mediated by the corticosteroid receptor since the corticosteroid

Fabrication of nanocrystal forms of ᴅ-cycloserine and their application for transdermal and enteric drug delivery systems

• Hsuan-Ang Tsai,
• Tsai-Miao Shih,
• Theodore Tsai,
• Jhe-Wei Hu,
• Yi-An Lai,
• Jui-Fu Hsiao and
• Guochuan Emil Tsai

Beilstein J. Nanotechnol. 2024, 15, 465–474, doi:10.3762/bjnano.15.42

• has shown significant treatment efficacy for central nervous system (CNS) disorders including depression, schizophrenia, Alzheimer’s disease, and post-traumatic stress disorder. The physicochemical properties of DCS, however, limit the options of formulation and medicinal applications of DCS, and

• and then to the in vitro Franz diffusion test with reservoir patch formulation as well as in vivo pharmacokinetics study with enteric capsules. We tested these formulations regarding their nanocrystal physical properties, size effect, and dissolution rate, respectively. We found that DCS nanocrystals

• ) and enteric formulation. In this study, DCS nanocrystals were fabricated and investigated for novel drug delivery systems. Transdermal drug delivery is an administration route wherein the API is delivered across the skin for systemic distribution. The categories of TDD systems include reservoir

Classification and application of metal-based nanoantioxidants in medicine and healthcare

• Nguyen Nhat Nam,
• Nguyen Khoi Song Tran,
• Tan Tai Nguyen,
• Nguyen Ngoc Trai,
• Nguyen Phuong Thuy,
• Hoang Dang Khoa Do,
• Nhu Hoa Thi Tran and
• Kieu The Loan Trinh

Beilstein J. Nanotechnol. 2024, 15, 396–415, doi:10.3762/bjnano.15.36

• , which are a cluster of hundreds to thousands atoms aggregated together [135]. The potential of natural antioxidant nanodelivery systems for treating age-related metabolic disorders has been proved in both in vivo and in vitro studies. For example, a nanoparticle-based formulation of curcumin exhibited

Nanomedicines against Chagas disease: a critical review

• Maria Jose Morilla,
• Kajal Ghosal and
• Eder Lilia Romero

Beilstein J. Nanotechnol. 2024, 15, 333–349, doi:10.3762/bjnano.15.30

• countries’ institutions (Brazil and Argentina), and private pharmaceutical companies. The project started proposing a sublingual formulation of BNZ within liposomes or lipid nanoparticles, assuming the intact formulations could reach the blood, avoid the hepatic first-pass metabolism, and reduce the

• authors showed comparable therapeutic effects to conventional treatment with free BNZ. These studies, however, did not compare the plasma levels of BNZ resulting from administering nanocrystals to rodents with identical doses of free BNZ. Other authors have recently reported the formulation of BNZ into

• self-nanoemulsified drug delivery systems (SNEDDSs). SNEEDSs provide a pediatric liquid formulation of BNZ, which is only marketed as solid tablets. SNEDDSs are isotropic mixtures of oil, surfactants, and co-surfactants that form submicrometer-droplet emulsions under agitation in water or